• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Maxim Integrated Reports Results For The Fourth Quarter Of Fiscal 2021

    7/27/21 4:03:00 PM ET
    $MXIM
    Semiconductors
    Technology
    Get the next $MXIM alert in real time by email

    SAN JOSE, Calif., July 27, 2021 /PRNewswire/ -- Maxim Integrated Products, Inc. (NASDAQ:MXIM) reported net revenue of $720 million for its fourth quarter of fiscal 2021 ended June 26, 2021, an 8% increase from the $665 million revenue recorded in the prior quarter, and a 32% increase from the same quarter of last year.

    Logo for Maxim Integrated Products, Inc. (PRNewsfoto/Maxim Integrated)

    "Maxim delivered record revenue in the June quarter, with sequential growth in all end markets, led by Industrial, Automotive, and Comms & Data Center. On the merger front, we are seeking final regulatory clearance for our combination with Analog Devices," said Tunc Doluca, President and Chief Executive Officer.

    Fiscal Year 2021 Fourth Quarter Results

    Based on Generally Accepted Accounting Principles (GAAP), diluted earnings per share in the June quarter was $0.93, which benefited from a $13 million tax reserve release. The results were affected by $6 million in pre-tax special items which primarily consisted of $4 million of expenses related to prior acquisitions and $2 million in charges related to our upcoming combination with Analog Devices. GAAP earnings per share, excluding special items was $0.91. An analysis of GAAP versus GAAP excluding special items is provided in this press release.

    Cash Flow Items

    At the end of the fourth quarter of fiscal 2021, total cash, cash equivalents and short-term investments were $2.3 billion, up $257 million from the prior quarter.

    Notable items included:

    • Cash flow from operations: $280 million
    • Capital expenditures: $20 million

    Trailing twelve months free cash flow was $859 million. Free cash flow is a non-GAAP measure and is defined by cash flow from operations less capital expenditures.

    Dividend and Stock Repurchase

    Per the terms of the Merger Agreement between the Company and Analog Devices, we will not declare a dividend that would have been paid in September 2021 and our stock repurchase program remains suspended.

    Due to the pending merger with Analog Devices, Maxim Integrated will not be hosting a quarterly earnings conference call and has suspended the practice of providing forward-looking guidance. Investors are requested to review our Investor Relations website for the quarterly financial highlights and SEC filings for the latest updates on the pending transaction with Analog Devices. 



























    CONSOLIDATED STATEMENTS OF INCOME



    (Unaudited)





























    Three Months Ended



    Year Ended







    June 26, 2021



    March 27, 2021



    June 27, 2020



    June 26, 2021



    June 27, 2020







    (in thousands, except per share data)





    Net revenues

    $         719,855



    $             665,029



    $         545,369



    $      2,632,529



    $      2,191,395





    Cost of goods sold

    235,830



    222,144



    183,001



    872,183



    758,743





    Gross margin

    484,025



    442,885



    362,368



    1,760,346



    1,432,652





    Operating expenses:























    Research and development

    114,834



    109,228



    110,173



    454,330



    440,166





    Selling, general and administrative

    81,071



    76,544



    72,893



    320,722



    296,722





    Intangible asset amortization

    846



    846



    810



    3,554



    3,078





    Severance and restructuring expenses

    1,139



    155



    678



    13,434



    5,363





    Other operating expenses (income), net

    2,798



    8,848



    (173)



    22,606



    929





    Total operating expenses

    200,688



    195,621



    184,381



    814,646



    746,258





    Operating income

    283,337



    247,264



    177,987



    945,700



    686,394





    Interest and other income (expense), net

    (5,723)



    (2)



    (8,488)



    (15,964)



    (8,298)





    Income before taxes

    277,614



    247,262



    169,499



    929,736



    678,096





    Provision for (benefit from) income taxes (1)(2)

    23,875



    27,199



    (37,799)



    102,475



    23,402





    Net income

    $         253,739



    $             220,063



    $         207,298



    $         827,261



    $         654,694





























    Earnings per share:























    Basic

    $               0.95



    $                   0.82



    $               0.78



    $               3.09



    $               2.43





    Diluted

    $               0.93



    $                   0.81



    $               0.77



    $               3.05



    $               2.41





























    Shares used in the calculation of earnings per share:























    Basic

    268,160



    267,892



    266,639



    267,546



    269,341





    Diluted

    271,445



    271,396



    268,777



    270,872



    272,028





























    Dividends paid per share

    $                   -



    $                      -



    $               0.48



    $               0.48



    $               1.92





















































    SCHEDULE OF SPECIAL ITEMS





    (Unaudited)





























    Three Months Ended



    Year Ended







    June 26, 2021



    March 27, 2021



    June 27, 2020



    June 26, 2021



    June 27, 2020







    (in thousands)





    Cost of goods sold:























    Intangible asset amortization

    $             3,047



    $                 4,430



    $             3,528



    $           17,408



    $           12,860





    Merger-related expenses(3)

    -



    -



    -



    2,394



    -





    Cost of COVID-19 response programs

    609



    638



    1,591



    2,750



    3,616





     Total 

    $             3,656



    $                 5,068



    $             5,119



    $           22,552



    $           16,476





























     Operating expenses: 























    Merger-related expenses(3)

    $             2,058



    $                 2,546



    $                   -



    $           26,617



    $                   -





    Intangible asset amortization

    846



    846



    810



    3,553



    3,078





    Severance and restructuring

    1,139



    155



    678



    13,434



    5,363





    Other operating expenses (income), net

    831



    6,302



    (173)



    7,436



    928





     Total 

    $             4,874



    $                 9,849



    $             1,315



    $           51,040



    $             9,369





























    Interest and other expense (income), net

    $            (2,878)



    $               (7,359)



    $             1,484



    $          (15,903)



    $               (541)





     Total 

    $            (2,878)



    $               (7,359)



    $             1,484



    $          (15,903)



    $               (541)





























    Provision for (benefit from) for income taxes:























    Impact of U.S. tax legislation (1)

    $                   -



    $                      -



    $             6,486



    $                   -



    $             6,486





    Impact of income tax audit settlements (2)

    -



    -



    (51,197)



    -



    (51,197)





     Total 

    $                   -



    $                      -



    $          (44,711)



    $                   -



    $          (44,711)





























    (1) Includes effect of U.S. tax legislation enacted on December 22, 2017.





    (2) Includes effect of income tax audit settlements.





    (3) Includes ADI merger related expenses such as accelerated stock-based compensation expense resulting from the acceleration of certain RSAs and RSUs, and other legal and professional services.



     



















    CONSOLIDATED  BALANCE SHEETS





    (Unaudited)







    June 26, 2021



    March 27, 2021



    June 27, 2020







    (in thousands)





    ASSETS





    Current assets:















    Cash and cash equivalents

    $      2,291,399



    $          2,033,973



    $      1,578,670





    Short-term investments

    -



    -



    35,536





    Total cash, cash equivalents and short-term investments

    2,291,399



    2,033,973



    1,614,206





    Accounts receivable, net

    658,829



    571,042



    404,778





    Inventories

    237,414



    242,343



    259,626





    Other current assets

    30,643



    27,440



    39,219





    Total current assets

    3,218,285



    2,874,798



    2,317,829





    Property, plant and equipment, net

    554,339



    543,848



    550,406





    Intangible assets, net

    66,998



    70,891



    87,959





    Goodwill

    562,540



    562,541



    562,540





    Other assets

    120,937



    120,149



    110,569





    TOTAL ASSETS

    $      4,523,099



    $          4,172,227



    $      3,629,303





















    LIABILITIES AND STOCKHOLDERS' EQUITY





    Current liabilities:















    Accounts payable

    $         129,710



    $             102,263



    $           91,982





    Price adjustment and other revenue reserves

    259,411



    214,366



    148,916





    Income taxes payable

    49,568



    53,694



    43,457





    Accrued salary and related expenses

    150,656



    128,553



    126,751





    Accrued expenses

    47,967



    35,627



    42,228





    Total current liabilities

    637,312



    534,503



    453,334





    Long-term debt

    995,460



    995,100



    994,022





    Income taxes payable

    343,964



    351,738



    385,072





    Other liabilities

    130,423



    141,721



    139,418





    Total liabilities

    2,107,159



    2,023,062



    1,971,846





















    Stockholders' equity:















    Common stock and capital in excess of par value

    269



    268



    266





    Additional paid-in capital

    58,055



    47,801



    -





    Retained earnings

    2,370,900



    2,117,161



    1,671,786





    Accumulated other comprehensive loss

    (13,284)



    (16,065)



    (14,595)





    Total stockholders' equity

    2,415,940



    2,149,165



    1,657,457





    TOTAL LIABILITIES & STOCKHOLDERS' EQUITY

    $      4,523,099



    $          4,172,227



    $      3,629,303



















     



    CONSOLIDATED STATEMENTS OF CASH FLOWS





    (Unaudited)







    Three Months Ended



    Year Ended







    June 26, 2021



    March 27, 2021



    June 27, 2020



    June 26, 2021



    June 27, 2020







    (in thousands, except per share data)





    Cash flows from operating activities:























    Net income

    $         253,739



    $             220,063



    $         207,298



    $         827,261



    $         654,694





    Adjustments to reconcile net income to net cash provided by operating activities:























    Stock-based compensation

    20,176



    20,878



    23,290



    107,993



    95,431





    Depreciation and amortization

    23,564



    24,552



    36,384



    96,456



    108,533





    Deferred taxes

    (4,047)



    1,601



    14,386



    (5,331)



    8,994





    In Process Research and Development written-off

    -



    -



    -



    1,220



    -





    Loss from sale or disposal of property, plant and equipment

    (611)



    124



    557



    (260)



    1,191





    Fair value contingent consideration

    -



    5,835



    -



    5,835



    -





    Other adjustments

    (95)



    2,413



    2,127



    1,745



    11,353





    Changes in assets and liabilities:























    Accounts receivable

    (87,794)



    (85,236)



    (24,078)



    (254,229)



    (42,335)





    Inventories

    4,890



    18,950



    (34,562)



    21,896



    (8,671)





    Other assets

    (6,759)



    (4,875)



    (25,769)



    (17,343)



    (86,299)





    Accounts payable

    17,384



    (719)



    5,405



    22,187



    7,594





    Price adjustment and other revenue reserves

    45,052



    34,118



    37,681



    110,673



    48,426





    Income taxes payable

    (11,900)



    8,021



    (45,855)



    (34,997)



    (74,814)





    All other accrued liabilities

    26,211



    25,715



    15,465



    41,154



    76,758





    Net cash provided by operating activities

    279,810



    271,440



    212,329



    924,260



    800,855





    Cash flows from investing activities:























    Purchases of property, plant and equipment

    (19,500)



    (16,229)



    (15,680)



    (64,942)



    (67,049)





    Proceeds from sales of property, plant and equipment

    11



    16



    124



    94



    392





    Proceeds from sales of available-for-sale securities

    -



    -



    1,290



    1,500



    1,290





    Proceeds from maturity of available-for-sale securities

    -



    8,876



    10,734



    33,901



    104,286





    Payment in connection with business acquisition, net of cash acquired

    -



    -



    (69,270)



    -



    (69,270)





    Purchases of investments in privately-held companies

    -



    (1,235)



    (1,840)



    (1,345)



    (1,960)





    Proceeds from sale of investments in privately-held companies

    242



    -



    205



    281



    378





    Other investing activities

    -



    -



    2



    -



    (116)





    Net cash provided by (used in) investing activities

    (19,247)



    (8,572)



    (74,435)



    (30,511)



    (32,049)





    Cash flows from financing activities:























    Contingent consideration paid

    -



    (10,000)



    -



    (10,000)



    (8,000)





    Net issuance of restricted stock units

    (9,964)



    (15,932)



    (6,741)



    (61,880)



    (35,877)





    Proceeds from stock options exercised

    82



    76



    2,240



    2,965



    18,870





    Issuance of common stock under employee stock purchase program

    -



    -



    23,725



    18,498



    42,260





    Repurchase of common stock

    -



    -



    (82,299)



    (9,201)



    (440,811)





    Dividends paid

    -



    -



    (128,058)



    (128,147)



    (517,162)





    Net cash used in financing activities

    (9,882)



    (25,856)



    (191,133)



    (187,765)



    (940,720)





    Net increase (decrease) in cash, cash equivalents and restricted cash 

    250,681



    237,012



    (53,239)



    705,984



    (171,914)





    Cash, cash equivalents and restricted cash 























    Beginning of period

    $      2,040,731



    $          1,803,719



    $      1,638,667



    $      1,585,428



    $      1,757,342





    End of period

    $      2,291,412



    $          2,040,731



    $      1,585,428



    $      2,291,412



    $      1,585,428





























    Total cash, cash equivalents, and short-term investments

    $      2,291,399



    $          2,033,973



    $      1,614,206



    $      2,291,399



    $      1,614,206





























    Cash, cash equivalents and restricted cash:























    Cash and cash equivalents

    $      2,291,399



    $          2,033,973



    $      1,578,670



    $      2,291,399



    $      1,578,670





    Restricted cash in Other assets

    13



    6,758



    6,758



    13



    6,758





    Total cash, cash equivalents and restricted cash

    $      2,291,412



    $          2,040,731



    $      1,585,428



    $      2,291,412



    $      1,585,428



























     



    ANALYSIS OF GAAP VERSUS GAAP EXCLUDING SPECIAL ITEMS DISCLOSURES





    (Unaudited)









    Three Months Ended



    Year Ended









    June 26, 2021



    March 27, 2021



    June 27, 2020



    June 26, 2021



    June 27, 2020









    (in thousands, except per share data)





    Reconciliation of GAAP gross profit to GAAP gross profit excluding special items:

























    GAAP gross profit



    $         484,025



    $             442,885



    $         362,368



    $      1,760,346



    $      1,432,652





    GAAP gross profit %



    67.2%



    66.6%



    66.4%



    66.9%



    65.4%





    Special items:

























    Intangible asset amortization



    3,047



    4,430



    3,528



    17,408



    12,860





    Merger-related expenses(1)



    -



    -



    -



    2,381



    -





    Cost of COVID-19 response programs



    609



    638



    1,591



    2,750



    3,616





    Severance and restructuring



    -



    -



    -



    13



    -





     Total special items 



    3,656



    5,068



    5,119



    22,552



    16,476





     GAAP gross profit excluding special items 



    $         487,681



    $             447,953



    $         367,487



    $      1,782,898



    $      1,449,128





     GAAP gross profit % excluding special items 



    67.7%



    67.4%



    67.4%



    67.7%



    66.1%































    Reconciliation of GAAP operating expenses to GAAP operating expenses excluding special items:

























    GAAP operating expenses



    $         200,688



    $             195,621



    $         184,381



    $         814,646



    $         746,258





    Special items:

























    Merger-related expenses(1)



    2,058



    2,546



    -



    26,617



    -





    Intangible asset amortization



    846



    846



    810



    3,553



    3,078





    Severance and restructuring



    1,139



    155



    678



    13,434



    5,363





    Other operating expenses (income), net



    831



    6,302



    (173)



    7,436



    928





     Total special items 



    4,874



    9,849



    1,315



    51,040



    9,369





     GAAP operating expenses excluding special items 



    $         195,814



    $             185,772



    $         183,066



    $         763,606



    $         736,889































    Reconciliation of GAAP net income to GAAP net income excluding special items:

























    GAAP net income



    $         253,739



    $             220,063



    $         207,298



    $         827,261



    $         654,694































    Special items:

























    Intangible asset amortization



    3,893



    5,276



    4,338



    20,961



    15,938





    Merger-related expenses(1)



    2,058



    2,546



    -



    29,011



    -





    Cost of COVID-19 response programs



    609



    638



    1,591



    2,750



    3,616





    Severance and restructuring



    1,139



    155



    678



    13,434



    5,363





    Other operating expenses (income), net



    831



    6,302



    (173)



    7,436



    928





    Interest and other expense (income), net



    (2,878)



    (7,359)



    1,484



    (15,903)



    (541)





     Pre-tax total special items 



    5,652



    7,558



    7,918



    57,689



    25,304





    Other income tax effects and adjustments (2)



    (12,950)



    (5,928)



    (14,378)



    (24,765)



    (19,668)





    Impact of U.S. tax legislation (3)



    -



    -



    6,486



    -



    6,486





    Impact of income tax audit settlements (4)



    -



    -



    (51,197)



    -



    (51,197)





     GAAP net income excluding special items 



    $         246,441



    $             221,693



    $         156,127



    $         860,185



    $         615,619































     GAAP net income per share excluding special items: 

























    Basic



    $               0.92



    $                   0.83



    $               0.59



    $               3.22



    $               2.29





    Diluted



    $               0.91



    $                   0.82



    $               0.58



    $               3.18



    $               2.26































    Shares used in the calculation of earnings per share excluding special items:

























    Basic



    268,160



    267,892



    266,639



    267,546



    269,341





    Diluted



    271,445



    271,396



    268,777



    270,872



    272,028































    (1) Includes ADI merger related expenses such as accelerated stock-based compensation expense resulting from the acceleration of certain RSAs and RSUs, and other legal and professional services.





    (2) Includes tax effect of pre-tax special items and miscellaneous tax adjustments.





    (3) Includes effect of U.S. tax legislation enacted on December 22, 2017.





    (4) Includes effect of income tax audit settlements.

















    Non-GAAP Measures

    To supplement the consolidated financial results prepared under GAAP, Maxim Integrated uses non-GAAP measures which are adjusted from the most directly comparable GAAP results to exclude special items related to the cost of COVID-19 response programs; ADI merger-related expenses; intangible asset amortization; severance and restructuring; other operating expenses (income), net; interest and other expense (income), net; and other income tax effects and adjustments. We defined free cash flow as net cash provided from operations less gross capital expenditures. Management uses these non-GAAP measures internally to make strategic decisions, forecast future results and evaluate Maxim Integrated's current performance. Many analysts covering Maxim Integrated use non-GAAP measures as well. Given management's use of these non-GAAP measures, Maxim Integrated believes these measures are important to investors in understanding Maxim Integrated's current and future operating results as seen through the eyes of management. In addition, management believes these non-GAAP measures are useful to investors in enabling them to better assess changes in Maxim Integrated's core business across different time periods. These non-GAAP measures are not in accordance with or an alternative to GAAP financial data and may be different from non-GAAP measures used by other companies. Because non-GAAP financial measures are not standardized it may not be possible to compare these financial measures with other companies' non-GAAP financial measures, even if they have similar names. The non-GAAP measures displayed in the table above include the following:

    GAAP Gross Profit Excluding Special Items

    The use of GAAP gross profit excluding special items allows management to evaluate the gross margin of the Company's core businesses and trends across different reporting periods on a consistent basis, independent of special items including intangible asset amortization, ADI merger-related expenses and cost of COVID-19 response programs. In addition, it is an important component of management's internal performance measurement and reward process as it is used to assess the current and historical financial results of the business, for strategic decision making, preparing budgets and forecasting future results. Management presents GAAP gross profit excluding special items to enable investors and analysts to evaluate our revenue generation performance relative to the direct costs of revenue of Maxim Integrated's core businesses.

    GAAP Operating Expenses Excluding Special Items

    The use of GAAP operating expenses excluding special items allows management to evaluate the operating expenses of the Company's core businesses and trends across different reporting periods on a consistent basis, independent of special items including intangible asset amortization; ADI merger-related expenses severance and restructuring, and other operating expenses (income), net. In addition, it is an important component of management's internal performance measurement and reward process as it is used to assess the current and historical financial results of the business, for strategic decision making, preparing budgets and forecasting future results. Management presents GAAP operating expenses excluding special items to enable investors and analysts to evaluate our core business and its direct operating expenses.

    GAAP Provision for Income Taxes Excluding Special Items

    The use of a GAAP provision for income taxes excluding special items allows management to evaluate the provision for income taxes across different reporting periods on a consistent basis, independent of special items. Special items include the tax impact of pre-tax special items, significant tax audit settlements, significant prior year tax reserve adjustments, significant tax legislation, and significant non-recurring and period specific tax items, which vary in size and frequency.

    GAAP Net Income and GAAP Net Income per Share Excluding Special Items

    The use of GAAP net income and GAAP net income per share excluding special items allow management to evaluate the operating results of Maxim Integrated's core businesses and trends across different reporting periods on a consistent basis, independent of special items including intangible asset amortization; ADI merger-related expenses; cost of COVID-19 response programs; severance and restructuring; other operating expenses (income), net; interest and other expense (income), net; and other income tax effects and adjustments. In addition, they are important components of management's internal performance measurement and reward process as it is used to assess the current and historical financial results of the business, for strategic decision making, preparing budgets and forecasting future results. Management presents GAAP net income and GAAP net income per share excluding special items to enable investors and analysts to understand the results of operations of Maxim Integrated's core businesses and to compare our results of operations on a more consistent basis against that of other companies in our industry.

    "Safe Harbor" Statement

    Except for historical information, this press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These statements involve risk and uncertainty. Actual results could differ materially from those forecasted, based upon, among other things, general market and economic conditions, regulatory approvals, supply constraints, market developments that could adversely affect the growth of the mixed-signal analog market, product mix shifts, the loss of all or a substantial portion of our sales to one or more of our large customers, customer cancellations and price competition, as well as other risks described in the Company's Annual Report on Form 10-K for the fiscal year ended June 27, 2020 (the "Form 10-K"). The Form 10-K may be found at https://www.sec.gov/Archives/edgar/data/743316/000074331620000025/0000743316-20-000025-index.htm.

    All forward-looking statements included in this news release are made as of the date hereof and based on the information available to the Company as of the date hereof. The Company assumes no obligation to update any forward-looking statement except as required by law.

    About Maxim Integrated

    Maxim Integrated, an engineer's engineering company, exists to solve the designer's toughest problems in order to empower design innovation. Our broad portfolio of high-performance semiconductors, combined with world-class tools and support, delivers essential analog solutions including efficient power, precision measurement, reliable connectivity and robust protection along with intelligent processing. Designers in application areas such as automotive, communications, consumer, data center, healthcare, industrial and IoT trust Maxim to help them quickly develop smaller, smarter and more secure designs. Learn more at https://www.maximintegrated.com.

    Contact

    Kathy Ta

    Vice President, Investor Relations

    (408) 601-5697

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/maxim-integrated-reports-results-for-the-fourth-quarter-of-fiscal-2021-301342480.html

    SOURCE Maxim Integrated Investor Relations

    Get the next $MXIM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MXIM

    DatePrice TargetRatingAnalyst
    8/19/2021$104.00 → $107.00Buy
    Deutsche Bank
    8/3/2021$95.00 → $100.00Equal-Weight
    Barclays
    More analyst ratings

    $MXIM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed

      SC 13G/A - MAXIM INTEGRATED PRODUCTS INC (0000743316) (Subject)

      2/16/21 12:23:42 PM ET
      $MXIM
      Semiconductors
      Technology
    • SEC Form SC 13G filed

      SC 13G - MAXIM INTEGRATED PRODUCTS INC (0000743316) (Subject)

      2/10/21 1:16:16 PM ET
      $MXIM
      Semiconductors
      Technology
    • SEC Form SC 13G/A filed

      SC 13G/A - MAXIM INTEGRATED PRODUCTS INC (0000743316) (Subject)

      2/10/21 11:22:48 AM ET
      $MXIM
      Semiconductors
      Technology

    $MXIM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Jain Vivek returned 61,064 units of Common Stock to the company, closing all direct ownership in the company to satisfy withholding tax

      4 - MAXIM INTEGRATED PRODUCTS INC (0000743316) (Issuer)

      8/30/21 9:17:52 PM ET
      $MXIM
      Semiconductors
      Technology
    • SEC Form 4: Medlin Edwin returned 75,090 units of Common Stock to the company, closing all direct ownership in the company (withholding obligation)

      4 - MAXIM INTEGRATED PRODUCTS INC (0000743316) (Issuer)

      8/30/21 9:16:55 PM ET
      $MXIM
      Semiconductors
      Technology
    • SEC Form 4: Preeshl Bryan returned 25,815 units of Common Stock to the company, closing all direct ownership in the company to cover taxes

      4 - MAXIM INTEGRATED PRODUCTS INC (0000743316) (Issuer)

      8/30/21 9:16:14 PM ET
      $MXIM
      Semiconductors
      Technology

    $MXIM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Medical Electronics Market size worth $ 8.45 Billion, Globally, by 2028 at 6.55% CAGR: Verified Market Research®

      JERSEY CITY, N.J., Jan. 31, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Medical Electronics Market" By Medical Device (MRI System, X-ray System, PET Scan System), By Application (Therapy Devices, Ventilator, Dialysis Machine, ECMO, Monitoring Devices), and By Geography. According to Verified Market Research, the Global Medical Electronics Market size was valued at USD 5.95 Billion in 2020 and is projected to reach USD 8.45 Billion by 2028, growing at a CAGR of 6.55% from 2021 to 2028. Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=156797 Browse in-depth TOC on "Medical Electronics Market" 202 - Pages126 – Tables37 – Figures

      1/31/22 11:00:00 AM ET
      $ADI
      $MXIM
      $TXN
      Semiconductors
      Technology
    • Lowest-Power ChipDNA PUF Technology from Analog Devices Secures Embedded Devices from Edge to Cloud

      WILMINGTON, Mass., Sept. 15, 2021 /PRNewswire/ -- Today Analog Devices, Inc. unveiled the ultra-low power MAXQ1065 cryptographic controller featuring its proprietary ChipDNA™ physically unclonable functionality (PUF) technology, which offers the strongest protection for edge-to-cloud Internet of Things (IoT) nodes, including medical and wearable devices, against invasive security attacks. The security co-processor provides 30x lower power when compared to similar products and its extended lifetime and operating range make it well-suited for long-term deployments in harsh environments. 

      9/15/21 8:00:00 AM ET
      $MXIM
      Semiconductors
      Technology
    • Analog Devices Completes Acquisition of Maxim Integrated

      Analog Devices, Inc. (NASDAQ:ADI) today announced the completion of its previously announced acquisition of Maxim Integrated Products, Inc. (NASDAQ:MXIM). The combination further strengthens ADI's position as a high-performance analog semiconductor company with trailing twelve-month revenue of over $9 billion1, industry leading margins, and free cash flow of over $3 billion1 on a pro forma basis. "Today is a tremendous milestone for ADI and I'm delighted to welcome the Maxim team, who share our passion for solving our customers' most complex technology problems," said Vincent Roche, President and CEO. "With more than 10,000 engineers and the increased breadth and depth of our best-in-class

      8/26/21 9:00:00 AM ET
      $ADI
      $MXIM
      Semiconductors
      Technology

    $MXIM
    SEC Filings

    See more
    • SEC Form 15-12B filed by Maxim Integrated Products, Inc.

      15-12B - MAXIM INTEGRATED PRODUCTS INC (0000743316) (Filer)

      9/7/21 4:13:53 PM ET
      $MXIM
      Semiconductors
      Technology
    • SEC Form 10-K/A filed by Maxim Integrated Products, Inc. (Amendment)

      10-K/A - MAXIM INTEGRATED PRODUCTS INC (0000743316) (Filer)

      9/7/21 4:10:10 PM ET
      $MXIM
      Semiconductors
      Technology
    • SEC Form S-8 POS filed by Maxim Integrated Products, Inc.

      S-8 POS - MAXIM INTEGRATED PRODUCTS INC (0000743316) (Filer)

      8/26/21 4:44:58 PM ET
      $MXIM
      Semiconductors
      Technology

    $MXIM
    Financials

    Live finance-specific insights

    See more
    • Analog Devices Completes Acquisition of Maxim Integrated

      Analog Devices, Inc. (NASDAQ:ADI) today announced the completion of its previously announced acquisition of Maxim Integrated Products, Inc. (NASDAQ:MXIM). The combination further strengthens ADI's position as a high-performance analog semiconductor company with trailing twelve-month revenue of over $9 billion1, industry leading margins, and free cash flow of over $3 billion1 on a pro forma basis. "Today is a tremendous milestone for ADI and I'm delighted to welcome the Maxim team, who share our passion for solving our customers' most complex technology problems," said Vincent Roche, President and CEO. "With more than 10,000 engineers and the increased breadth and depth of our best-in-class

      8/26/21 9:00:00 AM ET
      $ADI
      $MXIM
      Semiconductors
      Technology
    • Maxim Integrated Reports Results For The Fourth Quarter Of Fiscal 2021

      SAN JOSE, Calif., July 27, 2021 /PRNewswire/ -- Maxim Integrated Products, Inc. (NASDAQ:MXIM) reported net revenue of $720 million for its fourth quarter of fiscal 2021 ended June 26, 2021, an 8% increase from the $665 million revenue recorded in the prior quarter, and a 32% increase from the same quarter of last year. "Maxim delivered record revenue in the June quarter, with sequential growth in all end markets, led by Industrial, Automotive, and Comms & Data Center. On the merger front, we are seeking final regulatory clearance for our combination with Analog Devices," said

      7/27/21 4:03:00 PM ET
      $MXIM
      Semiconductors
      Technology
    • Maxim Integrated Reports Results For The Third Quarter Of Fiscal 2021

      SAN JOSE, Calif., April 27, 2021 /PRNewswire/ -- Maxim Integrated Products, Inc. (NASDAQ:MXIM) reported net revenue of $665 million for its third quarter of fiscal 2021 ended March 27, 2021, a 6% increase from the $628 million revenue recorded in the prior quarter, and a 18% increase from the same quarter of last year. "Maxim delivered record revenue in the March quarter, with sequential growth in all end markets. On a year-over-year basis, Automotive and Industrial revenue grew the strongest and comprised 64 percent of the total, up from 58 percent in the same quarter last y

      4/27/21 4:03:00 PM ET
      $MXIM
      Semiconductors
      Technology

    $MXIM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Deutsche Bank reiterated coverage on Maxim Integrated Products with a new price target

      Deutsche Bank reiterated coverage of Maxim Integrated Products with a rating of Buy and set a new price target of $107.00 from $104.00 previously

      8/19/21 8:27:57 AM ET
      $MXIM
      Semiconductors
      Technology
    • Barclays reiterated coverage on Maxim Integrated Products with a new price target

      Barclays reiterated coverage of Maxim Integrated Products with a rating of Equal-Weight and set a new price target of $100.00 from $95.00 previously

      8/3/21 8:04:39 AM ET
      $MXIM
      Semiconductors
      Technology
    • Deutsche Bank reiterated coverage on Maxim Integrated Products with a new price target

      Deutsche Bank reiterated coverage of Maxim Integrated Products with a rating of Buy and set a new price target of $104.00 from $100.00 previously

      5/20/21 8:54:51 AM ET
      $MXIM
      Semiconductors
      Technology